Enterprise Products Partners is a provider of midstream energy services to producers and consumers of natural gas, natural gas liquids (NGLs), crude oil, petrochemicals and refined products. The company's midstream energy operations include: natural gas gathering, treating, processing, transportation and storage; NGL transportation, fractionation, storage, and export and import terminals; crude oil gathering, transportation, storage, and export and import terminals; petrochemical and refined products transportation, storage, export and import terminals, and related services; and a marine transportation business that operates primarily on the U.S. inland and Intracoastal Waterway systems.

Graham designs, manufactures and sells equipment for the energy, defense and chemical/petrochemical industries. The company designs and manufactures custom-engineered ejectors, vacuum pumping systems, surface condensers and vacuum systems. The company is also a nuclear code accredited fabrication and specialty machining company which provides products to the commercial nuclear utility industry. The company's products are used in a range of industrial process applications, primarily in energy markets, including: petroleum refining, defense, chemical and petrochemical processing, power generation /alternative energy, and other.

HBT Financial a bank holding company. Through its subsidiaries, the company provides a comprehensive suite of business, commercial and retail banking products and services to businesses, families and local governments throughout Central and Northeastern Illinois. The company operates 61 full-service and three limited-service branch locations, and has a deposit share.

Opko Health is a healthcare company. The company manages two segments: Diagnostics, which provides laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health and correctional healthcare; and Pharmaceutical, which includes Rayaldee for the treatment of secondary hyperparathyroidism in adults with chronic kidney disease (CKD) and vitamin D insufficiency, and Alpharen (Fermagate Tablets) for the treatment of hyperphosphatemia in CKD patients requiring regular hemodialysis.

Panhandle Oil and Gas focuses on perpetual oil and natural gas mineral ownership through mineral acquisitions and the development of its mineral acreage inventory. In addition, the company owns interests in leasehold acreage and non-operated interests in oil and natural gas properties. The company's mineral and leasehold properties are located primarily in Oklahoma, North Dakota, Texas, Arkansas and New Mexico. The majority of the company's oil, natural gas liquids (NGL) and natural gas production is from wells located in Oklahoma, North Dakota, Texas and Arkansas. The company's principal products from the production associated with its non-operated interests are crude oil, natural gas and NGL.

Safehold is a holding company. Through its subsidiaries, the company operates its business through one segment by acquiring, managing and capitalizing ground leases. Ground leases generally represent the ownership of land underlying commercial real estate properties, which are leased on a long-term basis (base terms are 30 to 99 years, often with tenant renewal options) by the land owner to a tenant that owns and operates the building on top of the land, or what the company refer to as a Safehold?.

Sensient Technologies is a manufacturer and marketer of colors, flavors and fragrances. The company's three reportable segments are: Flavors & Fragrances Group, which develops, manufactures, and supplies flavor and fragrance systems for the food, beverage, personal care, and household-products industries; Color Group, which provides natural and synthetic color systems for use in foods, beverages, pharmaceuticals, and nutraceuticals, colors and other ingredients for cosmetics; and Asia Pacific Group, which provides a range of products from its Flavors & Fragrances Group and Color Group, as well as products developed by regional technical teams to appeal to local preferences.

Xeris Pharmaceuticals is a specialty pharmaceutical company, utilizing its non-aqueous formulation technology platforms, XeriSol and XeriJect, to develop and commercialize injectable and infusible drug formulations. The company's primary product candidate, Gvoke HypoPen, delivers glucagon via a commercially-available auto-injector for the treatment of severe hypoglycemia, a potentially life-threatening condition, in people with diabetes. In addition, the company is applying its technology platforms to convert other commercially-available drugs into room-temperature stable liquid formulations to address the needs in multiple therapeutic areas and conditions, including epilepsy and diabetes.